Events

SMi AI in Drug Discovery w/ Dr Dave Michalovich

Join our SVP of Precision Medicine, Dr Dave Michalovich, at the SMi AI in Drug Discovery Conference 2022.

AI-augmented mechanistic target identification at BenevolentAI

BenevolentAI has uniquely developed an AI-augmented, hypothesis-driven drug discovery platform that generates novel targets at scale.  In this talk, Dave Michalovich, SVP Precision Medicine, will explore how BenevolentAI bridges the worlds of drug discovery science and technology to help guide technologists in their work to develop AI tools that meet hyper-specific scientific requirements. Through use cases he will then demonstrate how BenevolentAI applies these tools to empower target identification, precision medicine and molecular design, citing BenevolentAI's work in novel target discovery, drug repurposing and in collaboration with large pharma.

Register here →



Dave Michalovich

SVP Precision Medicine

Dave is responsible for driving the Precision Medicine strategy at BenevolentAI, taking a patient-centric approach to understand disease endotypes, mechanisms and targets. Prior to joining BenevolentAI Dave was a Senior Scientific Director at GSK where he led discovery teams in the Adaptive Immunity Research Unit and Respiratory TA.

More Posts

You Might Also Like

News
BenevolentAI achieves third milestone in its AI-enabled drug discovery collaboration with AstraZeneca
AstraZeneca selects another novel target for idiopathic pulmonary fibrosis from the collaboration for its drug development portfolio.
May 17, 2022
Blog
FDA converts emergency approval of baricitinib — first identified as a COVID treatment by BenevolentAI — to a full approval
The FDA has converted its emergency approval of baricitinib to a full approval, underscoring the strength of BenevolentAI’s AI-derived hypothesis.
May 12, 2022
News
Notifications of persons discharging managerial responsabilities
May 5, 2022
News
PDMR Notification (Dr. Olivier Brandicourt)
May 5, 2022
News
PDMR Notification (Jean Raby)
May 5, 2022
News
Notifications of Major Holdings
Apr 29, 2022